Stay updated with breaking news from Suicidal Bipolar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NRX Pharmaceuticals announces Phase 2b/3 trial findings of NRX-101 vs. Lurasidone for Suicidal Bipolar Depression.
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q3 2023 Earnings Call Transcript November 14, 2023 Operator: Thank you for standing by. This is the conference operator. Welcome to NRX Pharmaceuticals’ Third Quarter 2023 Earnings Conference Call. As a reminder, all participants are in listen-only mode. The conference is being recorded. After the presentation, there will be an opportunity […]